ABSTRACT
BACKGROUND The modified early warning score (MEWS) is an objective measure of illness severity that promotes early recognition of clinical deterioration in critically ill patients. Its primary use is to; facilitate faster intervention or increase the level of care. Despite, its adoption in some African countries, MEWS is not standard of care in Ghana. We assessed the validity of MEWS as a predictor of mortality, among medically ill in-patients at the Korle-Bu Teaching Hospital (KBTH), Accra – Ghana. We sought to identify the predictive ability of MEWS in detecting clinical deterioration among medical in-patients and its comparability to the routinely measured vital signs.
METHOD This was a retrospective study of medical in-patients, aged ≥13 years and admitted at KBTH from January 2017 – March 2019. Vital signs at 48 hours post-admission were coded using MEWS criteria, to obtain a limited MEWS score (LMEWS) and the level of consciousness imputed to obtain a full MEWS score (MEWS). A predictive model comparing mortality among patients with “significant” MEWS (L/MEWS ≥4) and “non-significant” MEWS (L/MEWS <4) scores was designed using multiple logistic regression. Internally validated for predictive accuracy, using the Receiver Operating Characteristic (ROC) curve.
RESULTS 112 patients were included in the study. The adjusted odds of death comparing patients with a “significant” MEWS to patients with “non-significant” MEWS was 6.33(95% Cl 1.96 – 20.48). Similarly, the adjusted odds of death comparing patients with “significant” versus “non-significant” LMEWS was 8.22(95% CI 2.45 – 27.56). The ROC curve for each analysis had a C-static of 0.83 and 0.84 respectively.
CONCLUSION LMEWS is a good predictor of mortality and comparable to MEWS. Adoption of LMEWS can identify medical in-patients at risk of deterioration and death.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The research was funded by Leroy Burney family fund with no role in the design, collection, interpretation of data or writing & submission of manuscript. The authors declare that no competing interests exist.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval was obtained from the Institutional Review Board (IRB) of Johns Hopkins University, the Scientific and Technical Committee and the IRB of the Korle-Bu Teaching Hospital.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data is available upon request
